Cardiac mitochondrial function depends on BUD23 mediated ribosome programming.
5' Untranslated Regions
/ genetics
A549 Cells
Animals
Base Composition
/ genetics
Cardiomyopathies
/ metabolism
Embryo, Mammalian
Female
Humans
Male
Methyltransferases
/ genetics
Mice
Mitochondria
/ metabolism
Mitochondrial Proteins
/ genetics
Myocytes, Cardiac
/ cytology
Protein Interaction Maps
/ genetics
Ribosomes
/ genetics
cardiac
cell biology
human
mitochondria
mouse
protein translation
ribosome
Journal
eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614
Informations de publication
Date de publication:
15 01 2020
15 01 2020
Historique:
received:
30
07
2019
accepted:
24
12
2019
pubmed:
16
1
2020
medline:
20
4
2021
entrez:
16
1
2020
Statut:
epublish
Résumé
Efficient mitochondrial function is required in tissues with high energy demand such as the heart, and mitochondrial dysfunction is associated with cardiovascular disease. Expression of mitochondrial proteins is tightly regulated in response to internal and external stimuli. Here we identify a novel mechanism regulating mitochondrial content and function, through BUD23-dependent ribosome generation. BUD23 was required for ribosome maturation, normal 18S/28S stoichiometry and modulated the translation of mitochondrial transcripts in human A549 cells. Deletion of Cells need to make proteins to survive, so they have protein-making machines called ribosomes. Ribosomes are themselves made out of proteins and RNA (a molecule similar to DNA), and they are assembled by other proteins that bring ribosomal components together and modify them until the ribosomes are functional.Mitochondria are compartments in the cell that are in charge of providing it with energy. To do this they require several proteins produced by the ribosomes. If not enough mitochondrial proteins are made, mitochondria cannot provide enough energy for the cell to survive.One of the proteins involved in modifying ribosomes so they are functional is called BUD23. People with certain diseases, such as Williams-Beuren syndrome, do not make enough BUD23; but it was unknown what specific effects resulted from a loss of BUD23.To answer this question, Baxter et al. first genetically removed BUD23 from human cells, and then checked what happened to protein production. They found that ribosomes in human cells with no BUD23 were different than in normal cells, and that cells without BUD23 produced different proteins, which did not always perform their roles correctly. Proteins in the mitochondria are one of the main groups affected by the absence of BUD23. To determine what effects these modified mitochondrial proteins would have in an animal, Baxter et al. genetically modified mice so that they no longer produced BUD23. These mice developed heart problems caused by their mitochondria not working correctly and being unable to provide the energy the heart cells needed, eventually leading to heart failure. Heart problems are common in people with Williams-Beuren syndrome.Many diseases arise when a person’s mitochondria do not work properly, but it is often unclear why. These experiments suggest that low levels of BUD23 or faulty ribosomes may be causing mitochondria to work poorly in some of these diseases, which could lead to the development of new therapies.
Autres résumés
Type: plain-language-summary
(eng)
Cells need to make proteins to survive, so they have protein-making machines called ribosomes. Ribosomes are themselves made out of proteins and RNA (a molecule similar to DNA), and they are assembled by other proteins that bring ribosomal components together and modify them until the ribosomes are functional.Mitochondria are compartments in the cell that are in charge of providing it with energy. To do this they require several proteins produced by the ribosomes. If not enough mitochondrial proteins are made, mitochondria cannot provide enough energy for the cell to survive.One of the proteins involved in modifying ribosomes so they are functional is called BUD23. People with certain diseases, such as Williams-Beuren syndrome, do not make enough BUD23; but it was unknown what specific effects resulted from a loss of BUD23.To answer this question, Baxter et al. first genetically removed BUD23 from human cells, and then checked what happened to protein production. They found that ribosomes in human cells with no BUD23 were different than in normal cells, and that cells without BUD23 produced different proteins, which did not always perform their roles correctly. Proteins in the mitochondria are one of the main groups affected by the absence of BUD23. To determine what effects these modified mitochondrial proteins would have in an animal, Baxter et al. genetically modified mice so that they no longer produced BUD23. These mice developed heart problems caused by their mitochondria not working correctly and being unable to provide the energy the heart cells needed, eventually leading to heart failure. Heart problems are common in people with Williams-Beuren syndrome.Many diseases arise when a person’s mitochondria do not work properly, but it is often unclear why. These experiments suggest that low levels of BUD23 or faulty ribosomes may be causing mitochondria to work poorly in some of these diseases, which could lead to the development of new therapies.
Identifiants
pubmed: 31939735
doi: 10.7554/eLife.50705
pii: 50705
pmc: PMC7002040
doi:
pii:
Substances chimiques
5' Untranslated Regions
0
Mitochondrial Proteins
0
BUD23 protein, human
EC 2.1.1.-
Methyltransferases
EC 2.1.1.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : British Heart Foundation
ID : FS/18/4/33310
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L010240/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P00279X/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00015/4
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M008908/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P011853/2
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 107851/Z/15/Z
Pays : United Kingdom
Informations de copyright
© 2020, Baxter et al.
Déclaration de conflit d'intérêts
MB, MV, TP, GG, CP, LG, AK, KK, RM, MI, MZ, SP, EC, JG, LM, AA, NH, PR, MM, DB, AL, DR No competing interests declared
Références
J Pediatr Surg. 2011 Sep;46(9):1711-9
pubmed: 21929979
Apoptosis. 2007 May;12(5):913-22
pubmed: 17453160
Anal Biochem. 1976 May 7;72:248-54
pubmed: 942051
RNA. 2015 Feb;21(2):180-7
pubmed: 25525153
J Biol Chem. 2014 Mar 28;289(13):8931-46
pubmed: 24488492
Biomolecules. 2015 Jun 29;5(3):1319-38
pubmed: 26131977
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
Cell. 2009 Feb 20;136(4):731-45
pubmed: 19239892
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Front Physiol. 2013 May 10;4:102
pubmed: 23675354
Cell Metab. 2013 Nov 5;18(5):698-711
pubmed: 24206664
Genome Res. 2002 Apr;12(4):656-64
pubmed: 11932250
Biochim Biophys Acta Gen Subj. 2017 Nov;1861(11 Pt A):2822-2829
pubmed: 28778485
Nat Commun. 2017 Nov 13;8(1):1469
pubmed: 29133944
Proc Natl Acad Sci U S A. 2008 Jul 15;105(28):9757-62
pubmed: 18621680
Nat Methods. 2016 Sep;13(9):731-40
pubmed: 27348712
J Neurosci. 2013 Aug 7;33(32):12954-69
pubmed: 23926251
Genome Res. 2016 May;26(5):636-48
pubmed: 26984228
Elife. 2016 Jun 09;5:
pubmed: 27278775
PLoS One. 2015 Jul 27;10(7):e0133841
pubmed: 26214185
Clin Exp Pharmacol Physiol. 2013 Sep;40(9):671-81
pubmed: 23745944
Mol Cell Biol. 2008 May;28(10):3151-61
pubmed: 18332120
PLoS One. 2013 Sep 23;8(9):e75686
pubmed: 24086612
Nucleic Acids Res. 2017 Jan 4;45(D1):D183-D189
pubmed: 27899595
Proc Natl Acad Sci U S A. 2014 Dec 23;111(51):E5518-26
pubmed: 25489090
J Vis Exp. 2014 May 17;(87):
pubmed: 24893926
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Cell Rep. 2013 Jul 11;4(1):220-8
pubmed: 23827738
Elife. 2020 Jan 15;9:
pubmed: 31939735
Mol Cell Proteomics. 2014 Dec;13(12):3497-506
pubmed: 25225357
Mol Biol Cell. 2015 Jun 1;26(11):2080-95
pubmed: 25851604
Microsc Res Tech. 1994 Mar 1;27(4):307-18
pubmed: 8186449
Biomolecules. 2017 Jan 27;7(1):
pubmed: 28134793
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Cancer Res. 2011 Feb 1;71(3):1146-55
pubmed: 21148752
J Cell Biol. 1974 Jun;61(3):723-42
pubmed: 4836390
Biol Proced Online. 2016 Jun 21;18:13
pubmed: 27330413
Biochem J. 2011 Apr 15;435(2):297-312
pubmed: 21726199
Nucleic Acids Res. 2017 Jan 4;45(D1):D362-D368
pubmed: 27924014
RNA Biol. 2019 Feb;16(2):196-210
pubmed: 30638116
Cell. 2018 Mar 22;173(1):90-103.e19
pubmed: 29551269
J Proteome Res. 2016 Apr 1;15(4):1116-25
pubmed: 26906401
Biochem J. 2002 Oct 1;367(Pt 1):1-11
pubmed: 12117416
Mol Biol Cell. 2014 Sep 1;25(17):2542-55
pubmed: 25009282
Cell Signal. 2011 Oct;23(10):1534-45
pubmed: 21683788
Methods Mol Biol. 2012;810:25-58
pubmed: 22057559